These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6867047)

  • 1. Clearance concept in salivary drug excretion. Part II: Experiments.
    Zuidema J; van Ginneken CA
    Pharm Acta Helv; 1983; 58(5-6):136-43. PubMed ID: 6867047
    [No Abstract]   [Full Text] [Related]  

  • 2. Clearance concept in salivary drug excretion. Part I: theory.
    Zuidema J; van Ginneken CA
    Pharm Acta Helv; 1983; 58(3):88-93. PubMed ID: 6844361
    [No Abstract]   [Full Text] [Related]  

  • 3. Dependence of salivary drug concentration on salivary flow rate.
    Wood JH; Flora KP; Narasimhachari N; Baker CA
    Methods Find Exp Clin Pharmacol; 1982; 4(4):255-60. PubMed ID: 7121134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The passage of drugs into horse saliva and the suitability of saliva for pre-race testing.
    Horner MW
    Br J Sports Med; 1976 Oct; 10(3):133-40. PubMed ID: 1000158
    [No Abstract]   [Full Text] [Related]  

  • 5. The excretion of drugs in saliva. Antibiotics.
    Borzelleca JF; Cherrick HM
    J Oral Ther Pharmacol; 1965 Nov; 2(3):180-7. PubMed ID: 5849257
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug concentrations in plasma and saliva--physiologic and pharmacokinetic considerations].
    Posti J
    Pharm Acta Helv; 1979; 54(7-8):191-6. PubMed ID: 515107
    [No Abstract]   [Full Text] [Related]  

  • 7. Saliva-plasma drug concentration ratios during absorption: theoretical considerations and pharmacokinetic implications.
    Posti J
    Pharm Acta Helv; 1982; 57(3):83-92. PubMed ID: 7071071
    [No Abstract]   [Full Text] [Related]  

  • 8. Monitoring of drug concentrations in saliva: a non-invasive pharmacokinetic procedure.
    Ritschel WA; Tompson GA
    Methods Find Exp Clin Pharmacol; 1983 Oct; 5(8):511-25. PubMed ID: 6363838
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug content study of human saliva, bile and cerebrospinal fluid].
    Scherber A; Feller K; Terhaag B; Le Petit G; Richter K
    Farmakol Toksikol; 1982; 45(5):106-7. PubMed ID: 7140946
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanisms that regulate the passage of drugs into the saliva].
    Gasparini F; Miglioli PA; Berti A
    Arch Stomatol (Napoli); 1980; 21(2):311-5. PubMed ID: 6949519
    [No Abstract]   [Full Text] [Related]  

  • 11. A small animal model utilizing salivary drug excretion for pharmacokinetic determinations.
    Piraino AJ; DiGregorio GJ; Ruch EK
    J Pharmacol Methods; 1980 Jan; 3(1):1-7. PubMed ID: 7374168
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of pharmacokinetic variables in veterinary medicine using a computer program].
    Bache K; Kuhn B; Trolldenier H
    Arch Exp Veterinarmed; 1985 May; 39(3):296-308. PubMed ID: 3840351
    [No Abstract]   [Full Text] [Related]  

  • 13. Noninvasive chemical methods of estimating pharmacokinetic parameters.
    Graham GG
    Pharmacol Ther; 1982; 18(3):333-49. PubMed ID: 6762568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The elimination of drugs].
    Advenier C; Lhoste F
    Coeur Med Interne; 1978; 17(4):521-8. PubMed ID: 737996
    [No Abstract]   [Full Text] [Related]  

  • 15. Excretion of ofloxacin into saliva in rats with renal failure.
    Ding G; Naora K; Nagasako S; Hirano H; Iwamoto K
    J Pharmacol Exp Ther; 1998 Oct; 287(1):31-6. PubMed ID: 9765318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of age and salivary secretion rate on oral sugar clearance.
    Hase JC
    Swed Dent J Suppl; 1993; 89():1-65. PubMed ID: 8503094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of increasing levels of pharmaceutical penicillin G contamination on structure of free living nematode communities in experimental microcosms.
    Nasri A; Jouili S; Boufahja F; Hedfi A; Mahmoudi E; Aïssa P; Essid N; Beyrem H
    Environ Toxicol Pharmacol; 2015 Jul; 40(1):215-9. PubMed ID: 26148743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of CYP1A2 activity in clinical practice: why, how, and when?
    Faber MS; Jetter A; Fuhr U
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):125-34. PubMed ID: 16128905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The absorption and excretion of penicillin G and triple sulfas in four pediatric preparations in normal children.
    Novak E; Vitti TG; Gove RS; Hunt J; Ko H; Lummis WL
    Curr Ther Res Clin Exp; 1969 Jun; 11(6):384-9. PubMed ID: 4979987
    [No Abstract]   [Full Text] [Related]  

  • 20. Excretion of FDG into saliva and its significance for PET imaging.
    Stahl A; Dzewas B; Schwaiger M; Weber WA
    Nuklearmedizin; 2002 Oct; 41(5):214-6. PubMed ID: 12418306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.